Is the Commonwealth Bank of Australia share price a buy?

The Commonwealth Bank of Australia (ASX:CBA) share price has been hurt, is it a buy?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Commonwealth Bank of Australia (ASX: CBA) share price has recovered somewhat to $78.66 after the market has digested the AUSTRAC news of alleged money laundering problems.

Commonwealth Bank is the epitome of an Australian blue-chip share. It has a long history and a large market share, alongside a few other titans in the industry.

It has a varied source of income with loans, CommSec, financial planning and other areas.

However, it has seen some parts of its business come under pressure and criticism in recent times.

The financial planning arm has had a scandal. CommInsure has had a problem. There's a growing movement against Dollarmites due to its marketing nature. Now Commonwealth's ATMs were apparently not following reporting rules.

All of this negativity has led to the share price losing its premium to the other big banks.

Does this mean it's a buy?

Short-term problems usually make for a good time to buy shares for the long-term.

Commonwealth's share price certainly is more attractive now that it's $78.66 rather than above $85.

However, I believe that the Aussie banks could be about to go through a rough patch. High levels of debt and rising interest rates are going to hurt Commonwealth's cyclically-low bad debt.

I also think credit growth is going to materially slow as investors lose their appetite when they see property prices are no longer going up.

In the short-term the price may be more attractive, but over the next year or two I think the price could dip below $70 if not lower.

Foolish takeaway

If you think you're significantly underweight on Commonwealth Bank shares then now could be a little opportunity to add to your portfolio. However, I wouldn't be buying until I see the economy faltering.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »